Posted in | News

Atlas Copco Bags SEK 170 Million Order for Dynapac Pavers and Rollers

Atlas Copco (STO:ATCOA) (STO:ATCOB) has received an order for Dynapac-branded rollers and pavers from Xuzhou Gongli Road and Bridge Construction Machinery Co. Ltd, valued at approximately MSEK 170.

The order was signed at a formal ceremony during the Bauma exhibition in Shanghai, China.

The equipment will be used to construct highways, bridges, dams and airports throughout China and will be delivered during a six month period in 2010/2011. “We are proud to receive this large order for road construction equipment on the important Chinese market," says Björn Rosengren, Business Area President of Atlas Copco Construction and Mining Technique. “It shows that Chinese customers value the strong performance they get from Dynapac equipment and the added value we offer through our Chinese service and support organization." Xuzhou Gongli Road and Bridge Construction Machinery Co. Ltd is a rapidly growing construction equipment contractor that is doing business in five major provinces of China. The company was established in 1994 and operates out of Xuzhou, Jiangsu province, in East China.

Atlas Copco may be required to disclose the information provided herein pursuant to the Securities Markets Act. Atlas Copco is an industrial group with world-leading positions in compressors, construction and mining equipment, power tools and assembly systems. The Group delivers sustainable solutions for increased customer productivity through innovative products and services. Founded 1873, the company is based in Stockholm, Sweden, and has a global reach spanning more than 170 countries. In 2009, Atlas Copco had about 30 000 employees and revenues of BSEK 64 (BEUR 6.0).

Source: http://www.atlascopco.com

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.